What are the signs that Lung Cancer has recurred

Lung CancerMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Signs of Lung Cancer Recurrence

Lung cancer recurrence means the cancer has come back after treatment. This can happen in different ways, and knowing what to watch for is important for your ongoing care.

Types of Recurrence

According to the NCCN Guidelines for Non-Small Cell Lung Cancer, recurrences are divided into two main categories:

1. Locoregional Recurrence (cancer returns in the same area)

  • Cancer comes back in the lung or nearby lymph nodes
  • May affect the chest wall or airways

2. Distant Metastases (cancer spreads to other parts of the body)

  • Cancer spreads beyond the chest to organs like the brain, bones, liver, or adrenal glands

Physical Symptoms to Watch For

Depending on where the cancer recurs, you may notice:

Lung/Chest symptoms:

  • New or worsening cough
  • Coughing up blood (hemoptysis)
  • Chest pain or pressure
  • Shortness of breath or wheezing
  • Hoarseness in your voice

Brain metastases (if cancer spreads to the brain):

  • Headaches
  • Dizziness or balance problems
  • Weakness or numbness in parts of your body
  • Confusion or memory problems
  • Vision changes

Bone metastases (if cancer spreads to bones):

  • Bone pain, especially in the back, ribs, or hips
  • Weakness or numbness if spine is involved

Liver metastases:

  • Abdominal pain or swelling
  • Jaundice (yellowing of skin/eyes)
  • Unusual fatigue

General symptoms:

  • Unexplained weight loss
  • Persistent fatigue
  • Loss of appetite

How Recurrence is Detected

The NCCN Guidelines recommend regular surveillance imaging after treatment:

  • Chest CT scans - typically done every 3-6 months initially, then annually
  • Brain MRI - especially important if you have symptoms or certain risk factors
  • PET/CT scans - may be used if CT findings are unclear (to distinguish between scar tissue from radiation and actual cancer recurrence)

Important note: Areas previously treated with radiation can remain "active" on PET scans for up to 2 years, so your doctor may need to confirm findings with a biopsy.

Questions to Ask Your Healthcare Team

Since recurrence requires prompt evaluation and treatment decisions, consider asking:

  1. "What surveillance schedule should I follow after my treatment?" - This helps you know when to expect imaging and follow-up visits.

  2. "What specific symptoms should I report between appointments?" - Different cancer types and locations have different warning signs.

  3. "If imaging shows something suspicious, how will you determine if it's recurrence or scar tissue?" - This helps you understand the diagnostic process.

  4. "What treatment options exist if recurrence is found?" - Treatment depends on the type and location of recurrence, your overall health, and previous treatments.

  5. "How often should I have imaging, and for how long?" - Surveillance schedules vary based on your stage and treatment type.

Key Takeaway

Regular follow-up appointments and imaging are your best tools for catching recurrence early. Don't wait for symptoms—attend all scheduled surveillance visits. However, if you notice new symptoms between appointments, contact your oncology team promptly rather than waiting for your next scheduled visit.

According to the NCCN Guidelines, recurrence is common after lung cancer treatment, which is why ongoing surveillance is a standard part of your care plan.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: